Eli Lilly and Co. has reached an agreement with pharmaceutical Cipla to market tirzepatide, the active ingredient in Lilly’s ...

Indian drugmaker Cipla Limited has entered into a strategic marketing and distribution agreement with US pharma major Eli ...

It comes after a Manchester Evening News investigation revealed fake versions of an experimental drug were flooding social ...

They have dismantled a factory that made injections labelled as containing tirzepatide, the ingredient in Eli Lilly's ...

"This is a victory in the fight against the shameless criminals who are putting lives at risk by peddling dangerous and ...

The company is banking on key new launches, including weight loss drug Semaglutide and biosimilar Abatacept to drive growth ...

At least 2,000 pens labelled as containing tirzepatide and retatrutide were seized along with tens of thousands of empty pens ...

Britain's Medicines and Healthcare products Regulatory Agency seized a large cache of unlicensed weight-loss drugs, including ...

Novo Nordisk faces headwinds and leadership shifts, while Structure Therapeutics eyes pivotal obesity-drug data later this year.

Analysts believe that while the deal is positive, Cipla's share price is unlikely to see a fresh run-up, given the rise it ...

LLY's oncology portfolio, led by Verzenio, is set for double-digit growth as investors eye Q3 results beyond its obesity ...